Sign In
Buy LH
$254.43
-1.39 (-0.543%)
At Close: Jun 22, 2026
First FDA-approved, at-home screening test that uses RNA technology to detect biomarkers associated with colorectal cancer and advanced adenomas Designed to reduce common barriers to at-home screening
LH vs. CRL: Which Stock Is the Better Value Option?
12:41pm, Monday, 15'th Jun 2026
Investors looking for stocks in the Medical Services sector might want to consider either Labcorp Holdings (LH) or Charles River Laboratories (CRL). But which of these two stocks offers value investor
Why Labcorp Holdings (LH) is a Top Momentum Stock for the Long-Term
10:51am, Monday, 08'th Jun 2026
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here's Why Labcorp Holdings (LH) is a Strong Value Stock
10:40am, Friday, 05'th Jun 2026
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Labcorp Holdings Inc. (LH) Presents at Jefferies Global Healthcare Conference 2026 Transcript
02:22pm, Wednesday, 03'rd Jun 2026
Labcorp Holdings Inc. (LH) Presents at Jefferies Global Healthcare Conference 2026 Transcript
LH Expands Genetic Testing in CRC Through New Collab: Stock to Gain?
10:16am, Monday, 01'st Jun 2026
Labcorp joins a national CRC trial as exclusive genetic testing provider, expanding Invitae-based testing and supporting cancer research.
Labcorp Supports Multi-Institution Trial to Expand Genetic Testing in Colorectal Cancer
08:00am, Friday, 29'th May 2026
Labcorp Supports Multi-Institution Trial to Expand Genetic Testing in Colorectal Cancer PR Newswire BURLINGTON,
Labcorp Supports Multi-Institution Trial to Expand Genetic Testing in Colorectal Cancer
07:00am, Friday, 29'th May 2026
Collaborative trial with Alliance for Clinical Trials in Oncology will evaluate new approaches to increase germline genetic testing among at-risk family members Research will also assess the clinical
Labcorp Launches Expanded DPYD Test to Identify Cancer Patients at Risk for Severe Chemotherapy Side Effects
07:00am, Thursday, 28'th May 2026
New pharmacogenomic test detects all DPYD variants recommended by the Association for Molecular Pathology to support safer, more personalized cancer treatment BURLINGTON, N.C., May 28, 2026 /PRNewswir
LH or MEDP: Which Is the Better Value Stock Right Now?
12:41pm, Wednesday, 27'th May 2026
Investors looking for stocks in the Medical Services sector might want to consider either Labcorp Holdings (LH) or Medpace (MEDP). But which of these two stocks offers value investors a better bang fo
Labcorp to Present at the Jefferies Global Healthcare Conference
08:00am, Wednesday, 27'th May 2026
BURLINGTON, N.C., May 27, 2026 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that the company will present at the 2026 Jeffer
Labcorp (LH) Upgraded to Buy: Here's What You Should Know
01:01pm, Friday, 22'nd May 2026
Labcorp (LH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Should You Continue to Hold Labcorp Stock in Your Portfolio?
11:31am, Friday, 22'nd May 2026
LH gains from specialty testing growth, acquisitions and AI initiatives, but currency swings and macro pressures remain risks.
Why Labcorp Holdings (LH) is a Top Value Stock for the Long-Term
10:40am, Wednesday, 20'th May 2026
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Labcorp Launches MyLabcorp™, a New AI-Powered Mobile App Designed to Help Consumers Understand Lab Results and Track Health Trends Over Time
07:00am, Wednesday, 20'th May 2026
MyLabcorp connects lab results, educational content and AI-enabled features in a secure, personalized mobile experience Leverages OpenAI models designed to help users understand their results, ask que
